• Transcription Factor Reprogramming to Human Cardiomyocyte-li

  2026-07-08

  Romero-Tejeda et al. identify a novel transcription factor combination (MYOCD, SMAD6, TBX20) that enables efficient direct reprogramming of human fibroblasts into spontaneously contracting cardiomyocyte-like cells. Their high-throughput screening strategy, combined with small molecule and growth factor supplementation, marks a significant advancement toward clinically relevant cardiac regeneration.

• Annexin V-Cy5 Apoptosis Kit: Advancing Microglia Lysosomal S

  2026-07-07

  Explore how the Annexin V-Cy5 Apoptosis Kit enables precise, early apoptosis detection in microglial lysosomal stress models. This article offers a distinct, in-depth perspective on integrating apoptosis assays with real-time functional insights for neuroimmune research.

• Ibuprofen as an Anti-Proliferative Agent in Cancer Research

  2026-07-07

  Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) transcends its well-known role as an NSAID, empowering advanced cancer cell apoptosis and cell cycle arrest assays. This article details optimized experimental workflows, troubleshooting strategies, and translational insights for leveraging APExBIO’s Ibuprofen in oncology research.

• O-GlcNAcylation Regulates HUWE1–TfR1 Axis in Preeclampsia Fe

  2026-07-06

  This study uncovers how O-GlcNAc modification of HUWE1 controls TfR1 ubiquitination, regulating ferroptosis and supporting trophoblast syncytialization in preeclampsia. The findings clarify a mechanistic link between protein O-GlcNAcylation and placental iron homeostasis, opening new avenues for targeted placental biology research.

• Decoding Cell Death: TNF-alpha Recombinant Murine Protein in

  2026-07-06

  Explore how TNF-alpha recombinant murine protein enables precise investigation of apoptosis and immune modulation, leveraging new insights into regulated cell death pathways. This article offers advanced protocols and a unique analysis of signaling mechanisms beyond transcriptional loss.

• Ceftolozane Sulfate: Advanced Assay Workflows for Bactericid

  2026-07-05

  Ceftolozane sulfate delivers superior bactericidal activity against multidrug-resistant Pseudomonas aeruginosa, making it indispensable in both in vitro and in vivo antibacterial research. This guide translates recent PK/PD breakthroughs and workflow optimizations into actionable protocols and troubleshooting strategies for maximizing translational value.

• Oleic Acid (C18:1(9Z)) as a Translational Lever in Lipid Met

  2026-07-04

  This thought-leadership article explores the mechanistic role of Oleic Acid (C18:1(9Z)) in lipid metabolism and inflammation, providing translational researchers with strategic guidance on its use in experimental modeling. Drawing on recent hepatic ischemia-reperfusion injury (HIRI) research, it contextualizes Oleic Acid within clinical challenges and emerging therapeutic strategies, while offering structured protocol parameters and a forward-looking outlook. The discussion escalates beyond standard protocol guides, positioning APExBIO’s high-purity Oleic Acid as a cornerstone for robust, reproducible research in lipid signaling and metabolic disease.

• Baicalin and KEAP1-NRF2/HO-1 Pathway Modulation in Research

  2026-07-03

  Baicalin’s unique ability to modulate the KEAP1-NRF2/HO-1 pathway enables targeted manipulation of oxidative stress and neuroplasticity in both cancer and neuroscience research. This guide offers actionable workflows, protocol insights, and troubleshooting strategies to maximize the translational value of APExBIO’s high-purity Baicalin.

• Metabolic Intervention Enhances Ferroptosis and Cuproptosis

  2026-07-03

  The referenced study presents a nanosystem-based metabolic intervention that amplifies tumor cell sensitivity to both ferroptosis and cuproptosis by targeting glycolysis and NAD+ metabolism. This dual activation not only promotes regulated cell death but also remodels the tumor immune microenvironment, offering a promising strategy for improved anti-tumor therapies.

• SAR131675, a Selective VEGFR-3 Inhibitor: Reliable Lab Solut

  2026-07-02

  This article delivers scenario-driven, evidence-based guidance for using SAR131675, a selective and ATP-competitive VEGFR-3 inhibitor (SKU B2301), in cell viability, proliferation, and cytotoxicity workflows. We address reproducibility, selectivity, usability, and vendor reliability to help biomedical researchers achieve robust results in lymphangiogenesis and tumor studies.

• Lanabecestat (AZD3293): Precision BACE1 Inhibition Workflows

  2026-07-02

  Lanabecestat (AZD3293) enables researchers to modulate amyloid-beta production with nanomolar precision, offering synaptic-sparing BACE1 inhibition for Alzheimer’s disease research. This guide delivers protocol enhancements, troubleshooting insights, and pragmatic application strategies that leverage recent breakthroughs and empower reproducible preclinical workflows.

• FLAG tag Peptide (DYKDDDDK): Structural Insights and Protoco

  2026-07-01

  Explore the unique structural attributes and precise protocol optimization of the FLAG tag Peptide (DYKDDDDK) for recombinant protein detection. This article provides advanced, evidence-based guidance, deepening scientific understanding beyond standard workflows.

• Marein Restores Chemosensitivity by Inhibiting ABCG2 in MDR

  2026-07-01

  This study identifies marein, a chalcone flavonoid from Coreopsis tinctoria, as a potent and selective competitive inhibitor of the ABCG2 transporter, a key mediator of multidrug resistance (MDR) in cancer cells. By directly binding a critical residue on ABCG2, marein reverses drug resistance, significantly enhancing the efficacy of several chemotherapeutic agents.

• Cy5-UTP: Precision RNA Labeling for FISH and Transcriptomics

  2026-06-30

  Cy5-UTP (Cyanine 5-uridine triphosphate) transforms in vitro RNA labeling, enabling direct, quantifiable probe synthesis for high-sensitivity FISH and dual-color expression arrays. Its unique spectral profile and robust incorporation workflow streamline visualization and data quality, unlocking new avenues in transcriptomics and spatial RNA analysis.

• VX-765 and Blood-Brain Barrier Repair: Innovations in Caspas

  2026-06-30

  Explore how VX-765, a potent caspase-1 inhibitor, enables advanced research into blood-brain barrier repair and neuroinflammation. This article offers practical assay insights and unique translational context distinct from previous reviews.

451 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page